Table 1.
Association of GAS5 expression with clinicopathological features from CC patients.
| Features | n | High | Low | P |
|---|---|---|---|---|
| Age(years) | ||||
| ≥50 | 32 | 21 | 11 | 0.048* |
| <50 | 56 | 24 | 32 | |
| FIGO stage | ||||
| I and II | 19 | 7 | 12 | 0.199 |
| III and IV | 69 | 38 | 31 | |
| Tumour sizes | ||||
| ≥3 | 38 | 18 | 20 | 0.667 |
| <3F | 50 | 27 | 23 | |
| LN status | ||||
| Positive | 20 | 7 | 13 | 0.129 |
| Negative | 68 | 38 | 30 | |
| Histological grade | ||||
| Low differentiation | 30 | 15 | 15 | 0.878 |
| Moderate and high differentiation | 58 | 30 | 28 | |
| Vaginal recurrence or metastasis | ||||
| Present | 35 | 12 | 23 | 0.016* |
| Absent | 53 | 33 | 20 | |
| Chemotherapy | ||||
| Yes | 43 | 12 | 31 | 0.001* |
| No | 45 | 33 | 12 |
*P < 0.05.